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Abstract
About 3000 tons of beans are not used in human food due to hardening. Several studies on bean-derived bioactive peptides
have shown potential to treat some diseases, including those relying on oxidative dysfunctions. We assessed the effects of
peptides extracted from hardened bean Phaseolus vulgaris (PV) on reactive oxygen species (ROS) and nitric oxide (NO)
production, cytotoxic and cytoprotective effects in endothelial cells, and oxidonitrergic-dependent vasodilating effects. Extract
was composed by peptide fraction o3 kDa (PV3) from hardened common bean residue. PV3 sequences were obtained and
analyzed with bioinformatics. Human umbilical vein endothelial cells were treated with 10, 20, 30, and 250 mg/mL PV3.
Oxidative stress was provoked by 3% H2O2. Cytotoxicity and cytoprotective effects were evaluated by MTT assay, whereas,
ROS and NO were quantified using DHE and DAF-FM fluorescent probes by confocal microscopy. NO- and endothelium-
dependent vasodilating effects of PV3 were assessed in isolated aortic rings. We found 35 peptides with an average mass of
1.14 kDa. There were no cell deaths with 10 and 20 mg/mL PV3. PV3 at 30 mg/mL increased cell viability, while cytotoxicity was
observed only with 250 mg/mL PV3. PV3 at 10 mg/mL was able to protect cells from oxidative stress. PV3 also increased NO
release without causing cell death. It also reduced relative ROS production induced by H2O2. PV3 vasodilating effects relied on
endothelium-dependent NO release. PV3 obtained from low-commercial-value bean displays little cytotoxicity and exerts
antioxidant effects, whereas it increases endothelial NO release.
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Introduction
According to the global consumption ranking, Phaseo-
lus vulgaris (PV) is the third most important legume, pre-
ceded only by soybean (Glycine max) and peanut (Arachis
hypogea). For millions of people across the world, beans
are the major source of protein, dietary fiber, iron, complex
carbohydrates, minerals, and vitamins (1). Bean storage
should be a careful procedure, since grain cells are still alive,
and their metabolic processes remain active. Increases in
the time required for cooking due to excessive hardening of
the grain may be a consequence of damage resulting
from inadequate storage, such as: i) shell cracking due to
environmental low humidity; ii) pests and fungi; iii) bark
darkening that reflects morphological changes, commonly
found in lighter cultivars; and iv) grain weight loss (2). These
morphological, chemical, and physical changes result in a
condition known as the hard-to-cook (HTC) effect.
Insolubilization of pectic substances by the phytase
enzyme is a widely accepted mechanistic hypothesis (3);
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however, there are other enzymatic reactions that may
be involved in the hardening process. Among these
additional hypotheses, the following can be highlighted:
formation of insoluble pectates; increase in the content of
condensed tannins in the husk and migration of soluble
tannins to the grain cotyledons; complex formation
between tannins and medium lamella macromolecules;
denaturation and/or protein association; complex forma-
tion between polyphenols, proteins, and pectins; cell wall
lignification; oxidation and/or lipid polymerization (4).
These effects can be accelerated when storage conditions
have high air humidity (475%) and high temperatures
(30–40°C), which are characteristics of tropical countries
(5). Therefore, HTC beans are usually disposed of and as
a consequence, there is a large amount of non-commer-
cially viable residues. However, this amount of disposable
beans may still be used as a source of nutraceutical
components (6,7), thus avoiding food wasting and
obtaining some therapeutic benefits.
Several biological effects of protein extracts produced
from beans have been described, such as: antihypergly-
cemic (7), anticancer (8), ACE inhibitory and potentially
antihypertensive (9), anti-inflammatory (10), and antiox-
idant (11). Notwithstanding the aforementioned results
obtained in non-HTC, it is worth hypothesizing that HTC
beans may also serve as a source of bioactive com-
pounds. In this study, we purified a low molecular weight
peptide fraction (o3 kDa) from HTC Phaseolus vulgaris
(PV3) and assessed the potential oxidonitrergic and




The bean grains were supplied by the Brazilian
Agricultural Research Corporation (EMBRAPA) Rice and
Beans (Brazil), stored in a greenhouse for 120 days at
40°C (relative humidity of 75%). Flour was produced from
hand-peeled beans, passed through a knife mill, and then
sieved. The flour was stored in sealed plastic bags and
refrigerated at –20°C for further use.
The peptide fraction (o3 kDa) was from Phaseolus
vulgaris Pontal cultivar hardened common bean residue,
from the carioca commercial group. For peptide extraction,
5 mL of a solution containing acetonitrile, water, and
formic acid (ratio of 25:24:1) was added to every 1 g of
flour. The sample was stirred for 1 h at room temperature
and centrifuged at 11,200 g for 10 min at room tem-
perature. The supernatant underwent ultrafiltration on a
3 kDa membrane (Amicon Bioseparations, Germany).
Then, the extract was lyophilized and kept at 8°C. For
each test, the extract was diluted in saline (0.9% NaCl).
The filtrate obtained (peptides smaller than 3 kDa) in the
process was denominated PV3. The amount of protein in
the PV3 was determined by the Qubits Protein Assay kit
and Qubits Fluorometer (Invitrogen, USA).
PV3 peptidomics by mass spectrometry coupled
liquid chromatography (LC/MS-MS)
The samples were analyzed in a liquid chroma-
tography system (nano-UHPLC Dionex Ultimante 3.000)
coupled online to the Orbitrap Elitet hybrid ion trap-
orbitrap mass spectrometer (Thermo Scientific, Germany).
Two types of capillary columns were used in the chroma-
tographic system, a 100 mm  200 mm long internal
diameter pre-column packed in the laboratory with 5 mm
ReprosilPur 5 mm spherical silica particles with C18 Å
(Dr. Maisch, Germany) and a 75 mm  35 cm long analyt-
ical column, also packaged in the laboratory, with 3 mm
C18 Reprosil particles with 120 Å pores (Dr. Maisch).
Samples were eluted using a gradient of 98% solution A
(0.1% formic acid in water) to 35% solution B (0.1% formic
acid in ACN) over 155 min, 35 to 98% solution B for 5 min,
and 98% solution B for 8 min (a total of 168 min at 230 nL/
min). After each run, the column was equilibrated with
98% solution A. Mass spectra were acquired in positive
mode by applying data-dependent automatic survey MS
scan and tandem mass spectral acquisition (MS/MS). All
MS scans in the orbitrap (mass range: m/z 350–1650,
resolution: 120,000) were followed by MS/MS of the fifteen
most intense ions. Fragmentation by collision-induced
high energy dissociation (HCD) and repeated ion frag-
mentation were dynamically prevented.
Computational analysis
Peaks v.7.0 software (BSI Bioinformatics Solutions
Inc., Canada) was used to perform de novo sequencing
and peptide spectrum matches (PSM) search. The search
was performed against a database containing the proteins
found in the UniProt repository (www.uniprot.org), filtered
by Phaseolus vulgaris taxonomy ID (3885). Redundancies
were removed. The searches were performed with the
following parameters: 10 ppm MS tolerance, 0.05 Da MS/
MS tolerance, no cleavage agent was selected (since the
goal of this study was to analyze naturally occurring
peptides), methionine oxidation was selected as variable
modification. The number of proteins, the protein group,
and the number of peptides were filtered with a false
positive detection rate (FDR) of less than 1% and peptides
with rank 1 and minimum of 2 peptides per protein were
accepted for identification.
The sequenced peptides were analyzed following the
method of Mojica et al. (12). Sequence confirmation was
performed using BLASTs (https://blast.ncbi.nlm.nih.gov/
Blast.cgi, as accessed in February 27, 2020). Only pep-
tide sequences that showed alignment with the bean
genome were maintained in order to eliminate contaminants.
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The biological activity of the peptides was predicted using
the BIOPEP database (http://www.uwm.edu.pl/biochemia,
as accessed in February 27, 2020) (13).
Antioxidant effect of PV3 by DPPH assay
Antioxidant activity was determined using DPPH (2,2-
diphenyl-1-picrylhydrazyl) as an antioxidant agent. Two
hundred microliters of DPPH (0.15 mM) and 50 mL of
sample (concentrations ranging from 0.1 to 0.5 mg/mL)
were used. Following 15 min, samples were analyzed in a
microplate spectrophotometer (EPOCH) at a wavelength
of 520 nm. Determination of antioxidant activity was ex-
pressed through the calibration curve using Trolox (R2=
0.9956) (14).
Effect of PV3 on human endothelial cells
Human umbilical vein endothelial cells were pur-
chased from the Rio de Janeiro Cell Bank (UFRJ, Brazil)
originated from the ATCC (American Type Culture Collec-
tion, USA). Cultivation was performed in a humidified
incubator at 37°C and 5% CO2 in bottles using modified
Eagle’s Dulbecco’s medium (DMEM) plus 10% fetal
bovine serum, amphotericin B, and L glutamine (Cultilab,
Brazil).
After the cultivation step, the cells were quantified in a
Neubauer chamber and seeded onto 96-well plates
containing 200 mL DMEM medium at 1104 concentra-
tions. Then, the medium was discarded, and the wells
containing cells were treated with PV3 at concentrations of
10, 20, 30, and 250 mg/mL for 24 h. The negative control
group was treated with extract diluent, 0.9% (w/v) sodium
chloride solution. The positive control group was treated
with diluent and, after 24 h, was exposed to 3% (v/v)
hydrogen peroxide (H2O2) for one hour. All assays were
performed in three independent and triplicated experiments.
Effect of PV3 on cytotoxicity and cell viability assay by
tetrazolium reduction (MTT) assay. After the treatment
period, 10 mL of MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-
diphnyl-2H-tetrazolium], previously diluted in phosphate
buffered saline (PBS, in the ratio of 500 mg MTT to
100 mL PBS), was added to the plates and kept in a
humidified incubator for 3 h. Subsequently, 50 mL of 10%
sodium dodecyl sulfate (SDS, Vivantis Biochemical, Malay-
sia) was added to stop the reaction. The plates were kept at
room temperature for 24 h and protected from light.
The absorbance of the wells was quantified by spectro-
photometry (425–540 nm, Stat Fax 2100, Awareness
Technology Inc., USA). Graph production and statistical
tests were carried out using the GraphPad Prism program
(GraphPad Software, USA). Cytotoxicity (CT) was esti-
mated using the equation: %CT = 100 – (absorbance under
treatment/absorbance under control condition)  100.
To evaluate the cytoprotective potential of PV3 against
oxidative stress, after the cell treatment period, the super-
natant was discarded and a new medium containing 3%
(v/v) H2O2 was added. After one hour of exposure to the
H2O2 stressor, the plates were washed twice with PBS buffer
and tetrazolium reduction analysis was performed (15). The
specimens were observed with confocal microscopy (TCS
SP8 DMi8, Germany) on a 10 objective by Normarski
interferential differential contrast microscopy (DIC) to obtain
images of cells before and after treatment. Cell viability (CV)
was estimated by the equation: %CV = (absorbance under
treatment / absorbance under control condition)  100
Effect of PV3 on nitric oxide and free radical production.
This protocol was similar to previously described (16). To
evaluate whether PV3 treatment was able to induce nitric
oxide (NO) production, the cell confluents on a polarized
slide were incubated for 20 min at 37°C with 1 mM DAF-
FMt (Sigma-Aldrich, Germany). Then, the slide was
washed with PBS to remove excess probe. After 20 min,
cell images were taken with confocal microscopy (TCS SP8
DMi8) on 10 and 40 objective lenses. The product
generated by the reaction with the DAF-FM probe was
excited with the argon laser line at 488 nm and the
fluorescence emission intensity measured at 515 nm. The
product generated by the reaction with the DAPI probe was
excited with the Diode 405 laser line at 410 nn with the
fluorescence emission intensity measured at 360 nn.
Images from 10 different fields were captured in which
DAPI (fluorescent probe for DNA labelling) and DAF-FM
(fluorescent probe for NO detection) were analyzed,
generating three image markings: DNA, NO, and DNA
and NO merging.
To evaluate reactive oxygen species (ROS), after
treatment, the cell confluents on polarized slides were
incubated for 20 min at 37°C with 10 mM DHEt probe
(Thermo Fisher Scientific, EUA). Then, the slides were
washed with PBS to remove excess probe. After 20 min,
the product generated by the reaction with the DHE probe
was excited with the argon laser line at 496 nm and the
fluorescence emission intensity measured at 550 nm. DIC
microscopy was also used to obtain cell images without
revealing probe labelling. Images from 10 different fields
were captured in which the DHE labeling (fluorescent probe
for reactive oxygen species) was analyzed, thus generating
three images: ROS labeling, cells in DIC, and image
merging. This protocol was similar to that previously
described (17).
For quantitative analysis, Image J software (NIH, USA)
was used to enable the analysis of the pixels generated
from the specific excitation evoked from cell incubation with
DAF-FM and DHE. The amount of NO and ROS was
quantified as an average percentage of fluorescence pixels
detected in ten areas of 50 square micrometers.
Isolated aortic ring preparation
All experiments were approved by the local institu-
tional animal welfare committee at UFG (CEUA/UFG,
protocol number 084/2018) and were conducted in
accordance with the Brazilian Federal Law No. 11.794.
We made all efforts to minimize the number of animals
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used. The rats were maintained in controlled temperature
(22±2°C) with a 12-h light/dark cycle and had free access
to water and food. Isolated aortic rings from male Wistar
rats (250–300 g) were used to evaluate the vascular
effects of PV3, as follows.
Following decapitation, the descending thoracic aorta
was removed and sectioned into 4-mm rings. The aortic
rings were placed in 10 mL of organ bath at 37°C
containing gassed (95% O2 and 5% CO2) Krebs-Henseleit
solution (KHS) with the following composition: NaCl
(118.06 mM), KCl (4.6 mM), NaHCO3 (24.9 mM),
MgSO47H2O (2.4 mM), CaCl22H2O (3.3 mM), KH2PO4
(0.9 mM), and glucose (11.1 mM), pH 7.4. The rings were
fixed to an isometric force transducer under a tension of
1.5 g for 1 h for stabilization. The mechanical activity was
recorded using a data acquisition system (DATAQ Instru-
ments, USA). The vasorelaxant effect of PV3 was
investigated in rings with intact (E+) or denuded (E–)
endothelium. Endothelial integrity was assessed by the
degree of relaxation induced by acetylcholine (ACh, 10–5
mol/L) in rings pre-contracted with 10–7 mol/L phenylephr-
ine (Phe). Functional endothelium was considered when
Ach-induced relaxation was greater than 80%. In denuded
endothelium rings, the absence of functional endothelium
was verified by the absence of Ach-induced relaxation
rings pre-contracted with Phe. After an equilibration period
(30 min), the aortic rings were pre-constricted with Phe
(10–7 mol/L), and PV3 (10–7, 10–6, or 10–5 g/L) was added
to the KHS. In some experiments, the rings were pre-
incubated with the L-NAME (10–6 mol/L), a nitric oxide
synthase (NOS) inhibitor.
Statistical analysis
The data are reported as means±SE. Comparisons
were analyzed by two-way ANOVA, followed by Fisher
(for experiments in cells) and Sidak (for experiments in
isolated vessels) post hoc tests. All analyses were
performed using GraphPad Prism 6.0 software. The level
of significance was set at Po0.05. The cell culture tests
were performed in at least three independent replications
and the analyses were performed by comparing averages
of triplicates.
Results
Protein quantification of the extract revealed the
presence of 120.4±30.8 mg/g. Based on the UniProt
database, it was possible to identify 35 peptides present in
the PV3 extract that corresponded to 20 proteins from
Phaseolus vulgaris. The average length of the peptides
identified was 10.2 amino acids and average mass equal
to 1.14 kDa. The largest characterized peptide, PV3-A09,
has 23 amino acids in its composition and a mass of
2.35 KDa. The smallest peptides have 5 amino acids in
their primary structure. Supplementary Table S1 presents
the sequences, length, molecular weight, coverage, code
of the source protein (Uniprot), source protein length, and
biochemical characteristics of the source protein accord-
ing to Uniprot.
While assessing sequences by the BIOPEP software,
it was observed that many peptides had potential for
more than one biological activity. All sequences showed
potential for inhibiting ACE and DPP IV. The potential for
DPP III inhibition was present in 59% of the analyzed
sequences. A potential antioxidant predicted effect was
found in 41% of the sequences. Other bioactive potentials
predicted by the software were: stimulating effect in 29%
(for glucose uptake or release vasoactive substance),
renin inhibitor in 26%, regulator in 15% (activity of the
gastric mucous membrane or ion-flow regulators), medi-
ator of ubiquitin proteolysis activation in 15%, caMPDE
inhibitor in 15%, antiamnesia in 9%, antithrombotic in 9%,
anti-inflammatory in 9%, and hypolipidemic, neuropeptide,
and opioid in 3% for each. These results are detailed in
Table 1.
The antioxidant potential of the PV3 peptide fraction
was evaluated by the DPPH assay. The PV3 acted as a
donor of hydrogen atoms for the oxidoreduction reaction
and this resulted in an antioxidant effect, reducing 50% of
the DPPH radical at an IC50 of 7.74±0.33.
Figure 1 shows the results obtained from the MTT
assay, which determines cells viability and death induced
by incubation with PV3 at different concentrations and with
H2O2 as a potential cell damager (positive control). DIC
microscopy analysis (Figure 1A) was performed to double-
check the quantitative findings obtained by the MTTassay.
This method allowed demonstrating qualitatively PV3
effects in different concentrations with regard to the pos-
sible ability of preventing oxidative stress and of modifying
the amplitude of responses from an oxidative challenge.
As expected, H2O2 reduced cell viability. PV3 at
concentrations of 10 and 20 mg/mL did not cause cell
death compared to vehicle group (PV3 10 mg/mL: 96±3%
vs VEH: 100±1.7%; PV3 20 mg/mL: 96±0.6% vs VEH:
100±1.7%; Po0.05). PV3 30 mg/mL increased cell
viability (PV3 30 mg/mL: 110±0.4% vs 100±1.7%;
Po0.05). Cytotoxicity was found only at a concentration
of 250 mg/mL, causing 74% cell death, which was greater
than that triggered by H2O2 (PV3 250 mg/mL: 26.7±0.3%
vs VEH+H2O2: 50±1.1%; Po0.05). All groups differed
from H2O2 (VEH: 100±1.7% vs VEH+H2O2: 50±1.1%;
PV3 10 mg/mL: 96±3% vs VEH+H2O2: 50±1.1%; PV3
20 mg/mL: 96±0.6% vs VEH+H2O2: 50±1.1%; PV3
30 mg/mL: 110±0.4% vs VEH+H2O2 50±1.1%; PV3
250 mg/mL: 26.7±0.3% vs VEH+H2O2: 50±1.1%;
Po0.05) (Figure 1B).
The protective capacity of PV3 (preincubation) in
endothelial cells exposed to 3% (v/v) H2O2-induced
oxidative stress for 1 h was evaluated. This pretreatment
with PV3 was able to display a protective potential
at a concentration of 10 mg/mL (H2O2+PV3 10 mg/mL:
57.1±2% vs H2O2+VEH: 50.2±1.1%; Po0.05).
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Concentrations of 20 and 30 mg/mL showed similar cell
viability to the vehicle (H2O2+PV3 20 mg/mL: 47.9±0.3%
vs H2O2+VEH: 50±1.1%; H2O2+PV3 30 mg/mL:
48.1±2.4% vs H2O2+VEH: 50.2±1.1%; Po0.05). In
contrast, the only cytotoxic concentration was 250 mg/mL,
in which cell death was increased by 45% (H2O2+PV3
250 mg/mL: 27.6±1% vs VEH+H2O2: 50.2±.1.1%;
Po0.05) (Figure 1C).
The ability of the extract to increase NO release in
endothelial cells was evaluated and Figure 2 shows these
results obtained by confocal microscopy using the DAF-
FM probe. In order to evaluate the PV3 effect on NO
production in human endothelial cells, the PV3 concentra-
tion chosen was 10 mg/mL, i.e., that capable of exert-
ing protection against oxidative stress (PV3 10 mg/mL:
113.7±2% vs VEH+H2O2:100±2.0%; Po0.05) without


































































































































































GPWDGLAFVLLPVGSEPKDKGGL x x x x x1,2 x x x
MYSQDKIIANHIIKVHASAGR x x x x1
SGPADGLAFVLLPVGSEPKDK x x x x x1,2 x x x3 x
EVHLNKDSTPPSATRVSVV x x x x
TTSEALNLANFALNQIL x x x x1,2 x
TTRSPTFLGLEPAQSTK x x x x
SADGIAFALVPVGSQPK x x x x1
AKIQDKEGIPPDQQR x x x
SEALNLANFALNQIL x x x x1,2 x
EALNLANFALNQIL x x x x1,2 x
SKEGSEYANDAAQR x x x x2 x
GIAFALVPVGSQPK x x x x1
TPEAGSAEFTRGS x x x x x x
QDKEGIPPDQQR x x x
GPLINPVKSQSS x x x x x3
NLANFALNQIL x x x x1,2 x
TKDYVGDAAQK x x x x x4
VSDYADDAAQK x x x x4 x
APLGQNTVLLR x x x x x1 x x x
MQIFVKTLTG x x
EVEPLPHRK x x x
NDKEDSVFK x x
EGIPPDQQR x x x




EIRELR x x x x x x
ELREIR x x x x x
YDEPVR x x
ELEMR x x x
EIEMR x x x
ELELR x x x x
ELEIR x x x x x
EIEIR x x x x x
XIndicates that the peptide sequence described in the table lines would exert an effect according with columns; 1stimulant for glucose
uptake; 2stimulant to release vasoactive substance; 3regulates the activity of the gastric mucous membrane; 4ion flow regulators.
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Figure 1. A, Qualitative comparison of Phaseolus vulgaris peptide (PV3) treatments at different concentrations in pre-stress and post-
oxidative stress by 3% (v/v) H2O2 for 1 h (100 magnification, scale bar 250 mm, Nomarski interference contrast microscopy). B,
Evaluation of PV3 cytotoxicity at different concentrations in human endothelial cells by MTT assay. C, Evaluation of the cytoprotective
potential of PV3 pretreatment against oxidative stress caused by 3% H2O2 in MTT assay. The data are reported as means±SE.
*Po0.05 (ANOVA and Fisher test).
Figure 2. A, Effect of Phaseolus vulgaris peptide (PV3) extract on nitric oxide (NO) production with and without oxidative stress caused
by 3% H2O2 for 1 h by DAF-FM probe and confocal microscopy (scale bar 50 mm). B, Quantification of pixels generated from the specific
excitation of NO molecules. The data are reported as means±SE. Po0.05, different upper-case letters indicate that all groups differed
from each other (ANOVA and Fisher test).
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evoking cytotoxicity (PV3 10 mg/mL: 96±3% vs VEH:
100±1.7%; Po0.05). All treatments differed from vehicle
and from each other within this assay. H2O2 increased NO,
but the magnitude of this oxidonitrergic release was even
greater when cells were incubated with PV3. Interestingly,
the concomitant cell exposure to H2O2 and PV3 evoked NO
release, but these levels were lower than those obtained
only with PV3 (VEH: 1.2±0.2%; VEH+H2O2: 8.2±0.7%;
PV3 10 mg/mL: 19.2±1.1%; PV3+H2O2: 14.7±0.7%;
Po0.05 among groups) (Figure 2A and B).
The PV3 influence upon ROS was evaluated by DHE
probe and confocal microscopy, shown in Figure 3. PV3
(10 mg/mL) displayed a cytoprotective effect and was the
concentration of choice. As expected, ROS was increased
when the cells were exposed to H2O2 for 1 h (VEH:
8.5±1.3% vs VEH+H2O2: 25±1.1%; Po0.05). ROS
levels were lower in cells that underwent concomitant
treatment with PV3 10 mg/mL (VEH: 8.5±1.3% vs PV3 10
mg/mL: 3.6±0.2%; Po0.05). The previous (24 h) incuba-
tion of cells with PV3 attenuated the ROS increases
evoked by H2O2 (VEH+H2O2: 25±1.1% vs PV3+H2O2:
13±0.5%; Po0.05).
PV3 induced a significant relaxation at 10–6 and
10–5, but not at 10–7 g/L concentration in E+ vessels
(Figure 4A). The vasorelaxation induced by PV3 10–6 g/L
was completely blunted in E– aortic rings (Figure 4B),
thus indicating that PV3 effects are strongly dependent
on endothelium. Endothelium-dependent vasorelaxation
effects evoked by PV3 in isolated vessels was also
inhibited by the NOS inhibitor L-NAME (Figure 4C).
Discussion
The method of choice for obtaining PV3 did not use
techniques intended for chemical or physical digestion
of proteins, i.e., the 35 peptides identified are naturally
occurring in the grains. The extraction method we emp-
loyed was based on the solubility of the protein content in
the sample. By using formic acid with acetonitrile solution,
the solvation layer and the isoelectric point of the proteins
are simultaneously changed. The addition of acetonitrile
decreases the dielectric constant of the aqueous fraction
in the extracting solution, which changes the polarity of the
extract and results in an increased protein solubility with
low polarity (18). This method is effective for extraction of
amphipathic proteins and peptides. The peptide extract
generated from hardened bean residues with low com-
mercial value was tested for potential on cytotoxicity.
Figure 3. A, Confocal microscopy and DHE probe analysis of the effect of H2O2 and Phaseolus vulgaris peptide (PV3) on reactive
oxygen species (ROS) (scale bar 300 mm). B, Quantification of pixels generated from the specific excitation of ROS molecules The data
are reported as means±SE. Po0.05, different upper-case letters indicate that all groups differed from each other (ANOVA and Fisher
test).
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Subsequently, the PV3 effects on NO release and ROS
production were evaluated. Our findings also showed that
PV3 displayed little cytotoxicity whereas it reduced ROS
production and increased NO release in human endothe-
lial cells and in arteries.
The results on the antioxidant potential by DPPH
assay are in agreement with the antioxidant effect of bean
peptides previously reported. One prior study showed
antioxidant activity by reducing the DPPH radical in
proteins isolated from common bean (19). Other authors
obtained higher IC50 in DPPH essays: 153.2, 171.89, and
195.95 mg/mL in alkalase, trypsin, and flavorzyne hydro-
lysates, respectively (20). Following on from this previous
evidence, we suggest that the antioxidant activity we
found may rely on the aminoacidic composition, since the
presence of aromatic amino acid residues (such as
tryptophan, tyrosine, and phenylalanine) and of basic
amino acids (such as histidine and arginine) may underlie
antioxidant activity (21). This shall be supported by the
presence of these aforementioned aminoacidic com-
pounds among those detected in our LCMS assays.
Among the 35 peptides identified in the PV3 extract
(Table 1), four (PV3-A6, PV3-A7, PV3-A8, and PV3-A9)
showed a degree of alignment with a leucoagglutinating
phytohemagglutinin (PHA-L) with allergenic potential in
BALB/C mice (22). The peptides aligned to this protein
had low molecular weight (41.7 kDa), while the purified
PHA-L protein has a molecular weight of 29.5 kDa (22). It
is possible that biochemical events related to bean
hardening have degraded the protein into smaller pep-
tides. These fragments (i.e., the peptide content found in
PV3) may display a structural conformation that would be
insufficient for being allergenic in vivo. With the presence
of these fragments in PV3 arises the necessity for isola-
tion of these fragments and additional tests for assessing
the allergenic potential of PV3 should be conducted.
The BIOPEP software analyses showed that all
peptides identified in PV3 are potentially able to inhibit
ACE, a dipeptidylcarboxypeptidase that converts angio-
tensin I into the potent vasoconstrictor peptide angioten-
sin II. In addition, ACE is able to degrade bradykinin
(Bk), which is another pressor mechanism, since this Bk
degradation reduces the vasodilator effects that would be
exerted by binding to Bk receptors (23). In this regard,
ACE inhibition plays an important role in regulating blood
pressure, which explains a worldwide pharmacotherapeu-
tic choice in the management of hypertension and other
cardiovascular diseases (23). Many studies report bioac-
tive peptides derived from bean proteins with potential for
the treatment of hypertension, due to its ability to inhibit
ACE activity (21,24–26). The study of Tagliazucchi et al.
(26) identified that the peptide fraction derived from
Phaseolus vulgaris (also comprising molecules o3 kDa)
displays potent ACE inhibitory activity in vitro. This frac-
tion, however, was obtained following heating and enzy-
matic procedures. Contrastingly, the extraction method
adopted in our study raises the possibility that the natu-
rally occurring peptides present in PV3 would exert
cardiovascular effects by releasing NO, a potent endothe-
lium-derived relaxing factor that counteracts angiotensin II
constricting effects (27). This was confirmed by our
assays in isolated aortic rings (ex vivo), which showed
endothelium- and NO-dependent vasodilating effects
exerted by PV3. Therefore, further studies should be
conducted to verify the PV3 potential hypotensive/
antihypertensive effects in vivo.
It is noteworthy from current bioinformatics analyses
that almost all peptides present in PV3 extract may display
a DPP-IV inhibitory potential. DPP-IV is a metabolic
Figure 4. A, Effect of Phaseolus vulgaris peptide (PV3) (10–7, 10–6,
or 10–5 g/L) on the intact endothelium (E+) aortic rings. B, Effects of
PV3 (10–6 g/L ) in endothelium denuded (E–) vessels. C, PV3 (10–6
g/L) effects on E+ vessels incubated with nitric oxide synthase
(NOS) inhibitor L-NAME. The data are reported as means±SE.
**Po0.01; ***Po0.0001 (ANOVA and Sidak test).
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enzyme that can degrade and inactivate the glucagon-like
peptide-1 from incretins and the glucose-inhibiting poly-
peptide (28). These incretins induce an increase in insulin
secretion (insulinotropic activity) during the postprandial
period in response to food intake (28). DPP-IV inhibition
has been shown to improve glycemic regulation in type 2
diabetics (28). Several publications have also shown that
DPP-IV can be inhibited in vitro and in small animals
after ingesting hydrolysates and peptides derived from
food proteins (29,30). Our pioneer results identifying
peptides with potential DPP-IV inhibitory activity raise
the need for addressing PV3 effects upon in vivo glucose
metabolism.
The MTT assay showed that PV3 at concentrations of
10 and 20 mg/mL did not cause cell death. Also, treatment
with the concentration of 30 mg/mL increased cell viability.
Some peptides (PV3-A10 to PV3-A16) have aligned the
sequence with a phytohemagglutinin (PHA), known for
inducing leukocyte mitosis (31). In this regard, it is
possible that fragments of this mitosis-inducing protein
would be (at least partially) in charge of this increased cell
viability. Contrary to these advantageous effects found at
low concentrations, 76% of cell death was observed when
the concentration of PV3 was 250 mg/mL. Similar cytotoxic
effects of high concentrations on endothelial cells were
previously reported for several compounds that usually
display therapeutic effects at low concentration, which
include statins, thiazolidinediones, and even insulin (32,
33). On the other hand, when PV3 treatment was given
before inducing oxidative stress, there was an attenuation
on the oxidative effects on cell death levels compared with
those detected following H2O2 exposure, and this may
involve antioxidant effects (34).
PV3 increased NO and reduced ROS levels without
causing cell death. In addition, PV3 protected endothelial
cells from death by H2O2-induced oxidative stress through
ROS reducing mechanisms, which suggests a PV3
antioxidant effect. However, cells treated with a combina-
tion of PV3 and H2O2 showed a reduction in NO compared
to the group treated with PV3 alone. One possible
explanation for this result may be the complex composition
of peptides present in the extract. Similar effects occur with
resveratrol, which at low concentrations promotes antiox-
idant effects, whereas at higher concentrations, it may have
a dose-dependent pro-oxidant role likely followed by cell
damage and apoptosis (35). In addition, it was possible to
observe cells with conserved morphology when treated
with 10 mg/mL PV3 in relation to cells treated only with
vehicle or H2O2. This phenomenon persisted even when
PV3-treated cells were exposed to H2O2. It was also
observed that PV3-treated cells had higher NO concen-
tration/deposition in the nucleus whereas PV3+H2O2-
treated cells had higher cytoplasmatic NO concentration/
deposition. Endothelial dysfunction is known to occur due
to decreases in NO bioavailability and increases in
endothelin-1 (ET-1), angiotensin II, and oxidant levels,
which contribute to an imbalance in endothelium-derived
relaxing and constricting factors (36). Thus, it is not
implausible to propose that PV3 could improve endothelial
function in diseases such as arterial hypertension. This
hypothesis is further strengthened by the evidence from our
ex vivo assays: PV3 vasorelaxant actions rely on endothe-
lial-dependent oxidonitrergic paths. Since increases in NO
availability would also modify platelet aggregation (37), it is
worth suggesting concomitant beneficial endothelial and
platelet effects of PV3.
Epidemiological studies show that intake of whole
grains is correlated with a reduction in the incidence of
cardiovascular diseases, diabetes, and cancer (38,39). The
whole grain phytochemicals that exert antioxidant actions
may attenuate ROS contribution to the etiology and to the
pathophysiology of these diseases (27), thus resulting in
benefits for human health (40). Although there is still a need
for further (in vivo) studies, our data on the induction of NO
release and on the reduction of oxidative stress induced by
PV3 let us to propose that the current peptide extract would
be able to increase NO bioavailability concomitantly to
producing an antioxidant effect and this may be reached
even by the consumption of hardened bean as a nutra-
ceutical source.
We concluded that the low molecular weight peptide
extract produced from bean residues with no commercial
value displayed low cytotoxicity, reduced ROS, and
increased NO in endothelium. This study suggests the
PV3 potential therapeutic use to improve NO-dependent
physiological functions and to reduce oxidative stress.
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